Higher antiviral activity of antiretroviral regimens including protease inhibitors

被引：8

作者：

de Mendoza, C ^{[1
]}

Soriano, V ^{[1
]}

Rodríguez-Rosado, R ^{[1
]}

González-Lahoz, J ^{[1
]}

机构：

[1] Hosp Carlos III, Inst Salud Carlos III, Infect Dis Serv, Madrid, Spain

来源：

AIDS | 1999年 / 13卷 / 08期

关键词：

D O I：

10.1097/00002030-199905280-00021

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：998 / 999

页数：2

共 9 条

[1] Resisting resistance: Maximizing the durability of antiretroviral therapy [J].

Condra, JH .

ANNALS OF INTERNAL MEDICINE, 1998, 128 (11) :951-954

[2] HIV treatment strategies - Planning for the long term [J].

Gulick, RM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (12) :957-959

[3]

Günthard HF, 1998, J VIROL, V72, P2422

[4] Antiretroviral drug resistance testing in adults with HIV infection -: Implications for clinical management [J].

Hirsch, MS ;

Conway, B ;

D'Aquila, RT ;

Johnson, VA ;

Brun-Vézinet, F ;

Clotet, B ;

Demeter, LM ;

Hammer, SM ;

Jacobsen, DM ;

Kuritzkes, DR ;

Loveday, C ;

Mellors, JW ;

Vella, S ;

Richman, DD .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (24) :1984-1991

[5] An enhanced-sensitivity branched-DNA assay for quantification of human immunodeficiency virus type 1 RNA in plasma [J].

Kern, D ;

Collins, M ;

Fultz, T ;

Detmer, J ;

Hamren, S ;

Peterkin, JJ ;

Sheridan, P ;

Urdea, M ;

White, R ;

Yeghiazarian, T ;

Todd, J .

JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (12) :3196-3202

[6] HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time [J].

Perelson, AS ;

Neumann, AU ;

Markowitz, M ;

Leonard, JM ;

Ho, DD .

SCIENCE, 1996, 271 (5255) :1582-1586

[7] Protease inhibitor-containing regimens compared with nucleoside analogues alone in the suppression of persistent HIV-1 replication in lymphoid tissue [J].

Ruiz, L ;

van Lunzen, J ;

Arno, A ;

Stellbrink, HJ ;

Schneider, C ;

Rull, M ;

Castellà, E ;

Ojanguren, I ;

Richman, DD ;

Clotet, B ;

Tenner-Racz, K .

AIDS, 1999, 13 (01) :F1-F8

[8] Protease inhibitors as initial therapy for individuals with an intermediate risk of HIV disease progression: is more necessarily better? [J].

Schechter, M ;

Struchiner, CJ ;

Harrison, LH .

AIDS, 1999, 13 (01) :97-102

[9] QUANTIFICATION OF HIV-1 RNA IN PLASMA USING NASBA (TM) DURING HIV-1 PRIMARY INFECTION [J].

VANGEMEN, B ;

KIEVITS, T ;

SCHUKKINK, R ;

VANSTRIJP, D ;

MALEK, LT ;

SOOKNANAN, R ;

HUISMAN, HG ;

LENS, P .

JOURNAL OF VIROLOGICAL METHODS, 1993, 43 (02) :177-188

← 1 →